HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neonatal rotavirus infection and its relation to cord blood antibodies.

Abstract
Among 274 neonates born at the maternity services of an urban hospital in India, 36.1% of the infants shed rotavirus in feces (as detected by ELISA) by 72 h of life. The excretion rate increased to 70.3% among the 120 infants who stayed for 5 days or more at the hospital. Diarrhoeal symptoms of mild and self-limited nature were observed only in 19.2% of the rotavirus excretors, the remaining being asymptomatic. Among the 98 infants who received supplement feeds, 49% acquired rotavirus infection as against 24.7% of the 150 exclusively breast fed infants (p less than 0.001). Viral RNA in the feces of all rota positive infants showed the same electropherotype, indicating infection from a common source. The mean percentage rotavirus inhibitory activity of cord sera in the infected and non-infected infants was 50.2 +/- 21.7 and 56.6 +/- 19.2 respectively (p greater than 0.05), suggesting that cord blood antibodies do not offer significant protection against neonatal rotavirus infection.
AuthorsS Jayashree, M K Bhan, P Raj, R Kumar, L Svensson, G Stintzing, N Bhandari
JournalScandinavian journal of infectious diseases (Scand J Infect Dis) Vol. 20 Issue 3 Pg. 249-53 ( 1988) ISSN: 0036-5548 [Print] England
PMID3406664 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Viral
  • RNA, Viral
Topics
  • Antibodies, Viral (analysis)
  • Bottle Feeding (adverse effects)
  • Breast Feeding
  • Cross Infection (epidemiology)
  • Diarrhea, Infantile (microbiology)
  • Enzyme-Linked Immunosorbent Assay
  • Feces (microbiology)
  • Fetal Blood (immunology)
  • Humans
  • India
  • Infant, Low Birth Weight (microbiology)
  • Infant, Newborn
  • Nurseries, Hospital
  • RNA, Viral (analysis)
  • Rotavirus Infections (epidemiology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: